Skip to main content Accessibility help
×
Home

Treatment for Positive Urine Cultures in Hospitalized Adults: A Survey of Prevalence and Risk Factors in 3 Medical Centers

  • Jonathan D. Grein (a1), Katherine L. Kahn (a2), Samantha J. Eells (a3) (a4) (a5), Seong K. Choi (a6), Marianne Go-Wheeler (a7), Tanzib Hossain (a7) (a8), Maya Y. Riva (a9), Megan H. Nguyen (a3) (a9) (a10), A. Rekha Murthy (a1) and Loren G. Miller (a3)...

Abstract

BACKGROUND

Antibiotic treatment for asymptomatic bacteriuria (ASB) is prevalent but often contrary to published guidelines.

OBJECTIVE

To evaluate risk factors for treatment of ASB.

DESIGN

Retrospective observational study.

SETTING

A tertiary academic hospital, county hospital, and community hospital.

PATIENTS

Hospitalized adults with bacteriuria.

METHODS

Patients without documented symptoms of urinary tract infection per Infectious Diseases Society of America (IDSA) criteria were classified as ASB. We examined ASB treatment risk factors as well as broad-spectrum antibiotic usage and quantified diagnostic concordance between IDSA and National Healthcare Safety Network criteria.

RESULTS

Among 300 patients with bacteriuria, ASB was present in 71% by IDSA criteria. By National Healthcare Safety Network criteria, 71% of patients had ASB; within-patient diagnostic concordance with IDSA was moderate (kappa, 0.52). After excluding those given antibiotics for nonurinary indications, antibiotics were given to 38% (62/164) with ASB. Factors significantly associated with ASB treatment were elevated urine white cell count (65 vs 24 white blood cells per high-powered field, P<.01), hospital identity (hospital C vs A, odds ratio, 0.34 [95% CI, 0.14–0.80], P =.01), presence of leukocyte esterase (5.48 [2.35–12.79], P<.01), presence of nitrites (2.45 [1.11–5.41], P=.03), and Escherichia coli on culture (2.4 [1.2–4.7], P=.01). Of patients treated for ASB, broad-spectrum antibiotics were used in 84%.

CONCLUSIONS

ASB treatment was prevalent across settings and contributed to broad-spectrum antibiotic use. Associating abnormal urinalysis results with the need for antibiotic treatment regardless of symptoms may drive unnecessary antibiotic use.

Infect. Control Hosp. Epidemiol. 2016;37(3):319–326

Copyright

Corresponding author

Address correspondence to Jonathan D. Grein, MD, David Geffen School of Medicine at UCLA, Department of Hospital Epidemiology, Cedars-Sinai Medical Center, 8635 W Third St, Ste 1150-West, Los Angeles, CA 90048 (Jonathan.Grein@cshs.org).

Footnotes

Hide All

Presented in part: IDWeek; Philadelphia, Pennsylvania; October 9, 2014 (abstract 143).

Footnotes

References

Hide All
1. Centers for Disease Control and Prevention. Antibiotic resistance threats in the United States, 2013. CDC website. http://www.cdc.gov/drugresistance/threat-report-2013/index.html. Accessed June 23, 2014.
2. Fridkin, S, Baggs, J, Fagan, R, et al. Vital signs: improving antibiotic use among hospitalized patients. MMWR Morb Mortal Wkly Rep 2014;63:194200.
3. Gandhi, T, Flanders, SA, Markovitz, E, Saint, S, Kaul, DR. Importance of urinary tract infection to antibiotic use among hospitalized patients. Infect Control Hosp Epidemiol 2009;30:193195.
4. Nicolle, LE, Bradley, S, Colgan, R, Rice, JC, Schaeffer, A, Hooten, TM. Infectious Diseases Society of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults. Clin Infect Dis 2005;40:643654.
5. Hooten, TM, Bradley, SF, Cardenas, DD, et al. Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 international clinical practice guidelines for the Infectious Diseases Society of America. Clin Infect Dis 2010;50:625663.
6. Dull, RB, Friedman, SK, Risoldi, ZM, Rice, EC, Starlin, RC, Destache, CJ. Antimicrobial treatment of asymptomatic bacteriuria in noncatheterized adults: a systematic review. Pharmacotherapy 2014;34:941960.
7. Trautner, BW, Grigoryan, L. Approach to a positive urine culture in a patient without urinary symptoms. Infect Dis Clin North Am 2014;28:1531.
8. Shaughnessy, MK, Amundson, WH, Kuskowski, MA, DeCarolis, DD, Johnson, JR, Drekonja, DM. Unnecessary antimicrobial use in patients with current or recent Clostridium difficile infection. Infect Control Hosp Epidemiol 2013;34:109116.
9. Silver, SA, Baillie, L, Simor, AE. Positive urine cultures: a major cause of inappropriate antimicrobial use in hospitals? Can J Infect Dis Med Microbiol 2009;20:107111.
10. Cope, M, Cevallos, ME, Cadle, RM, et al. Inappropriate treatment of catheter-associated asymptomatic bacteriuria in a tertiary care hospital. Clin Infect Dis 2009;48:11821188.
11. Dalen, DM, Zvonar, RK, Jessamine, PG. An evaluation of the management of asymptomatic catheter-associated bacteriuria and candiduria at the Ottawa Hospital. Can J Infect Dis Med Microbiol 2005;16:166170.
12. Lin, E, Bhusal, Y, Horwitz, D, Shelburne, SA, Trautner, BW. Overtreatment of enterococcal bacteriuria. Arch Intern Med 2012;172:3338.
13. Ifran, N, Brooks, A, Mithoowani, S, Celetti, SJ, Main, C, Mertz, D. A controlled quasi-experimental study of an educational intervention to reduce the unnecessary use of antimicrobials for asymptomatic bacteriuria. PLOS ONE 2015;10:e0132071.
14. File, TM, Solomkin, JS, Cosgrove, SE. Strategies for improving antimicrobial use and the role of antimicrobial stewardship programs. Clin Infect Dis 2011;53:S15S22.
15. Choosing Wisely website. www.choosingwisely.org. Accessed October 2, 2015.
16. Gross, PA, Patel, B. Reducing antibiotic overuse: a call for a national performance measure for not treating asymptomatic bacteriuria. Clin Infect Dis 2007;45:13351337.
17. Catheter-associated urinary tract infection (CAUTI) event. National Healthcare Safety Network website. http://www.cdc.gov/nhsn/acute-care-hospital/CAUTI/index.html. Accessed August 30, 2013.
18. Chant, C, Dos Santos, CC, Saccucci, P, Smith, OM, Marshall, JC, Friedrich, JO. Discordance between perception and treatment practices associated with intensive care unit-acquired bacteriuria and funguria: a Canadian physician survey. Crit Care Med 2008;36:11581167.
19. Trautner, BW, Petersen, NJ, Hysong, SJ, Horwitz, D, Kelly, PA, Naik, AD. Overtreatment of asymptomatic bacteriuria: identifying provider barriers to evidence-based care. Am J Infect Control 2014;42:653658.
20. Drekonja, DM, Abbo, LM, Kuskowski, MA, Gnadt, C, Shukla, B, Johnson, JR. A survey of resident physician’s knowledge regarding urine testing and subsequent antimicrobial treatment. Am J Infect Control 2013;41:892896.
21. Gupta, K, Hooton, TM, Naber, KG, et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis 2011;52:e103e120.
22. Werner, NL, Hecker, MT, Sethi, AK, Donskey, CJ. Unnecessary use of fluoroquinolone antibiotics in hospitalized patients. BMC Infect Dis 2011;11:187.
23. Cohen, SH, Gerding, DN, Johnson, S, et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infect Control Hosp Epidemiol 2010;31:431455.
24. Khair, HN, VanTassell, P, Henderson, JP, Warren, DK, Marschall, J, for the CDC Prevention Epicenters Program. Vancomycin resistance has no influence on outcomes of enterococcal bacteriuria. J Hosp Infect 2013;85:183188.
25. Viera, AJ, Garrett, JM. Understanding interobserver agreement: the kappa statistic. Fam Med 2005;37:360363.
26. Pavese, P, Saurel, N, Labarere, J, et al. Does an educational session with an Infectious Diseases physician reduce the use of inappropriate antibiotic therapy for inpatients with positive urine culture results? A controlled before-and-after study. Infect Control Hosp Epidemiol 2009;30:596599.
27. Slimings, C, Riley, TV. Antibiotics and hospital-acquired Clostridium difficile infection: update of systematic review and meta-analysis. J Antimicrob Chemother 2014;69:881891.
28. Dellit, TH, Owens, RC, McGowan, JE, et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis 2007;44:159177.

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed